Solving the $100,000 Cancer Drug Problem
Harvard Business Review
MAY 2, 2013
These researchers opined that high prices are preventing patients from being treated, and they questioned the ethics of pharmaceutical companies. for instance, even insured patients pay an average of 20% of drug prices out-of-pocket, meaning these drugs can cost a patient $20,000 a year. This cost structure enables pricing flexibility.
8 
Let's personalize your content